Photo-damage promoted by tetra-cationic palladium(II) porphyrins in rapidly growing mycobacteria

Photodiagnosis Photodyn Ther. 2021 Dec:36:102514. doi: 10.1016/j.pdpdt.2021.102514. Epub 2021 Sep 1.

Abstract

Antimicrobial photodynamic therapy (aPDT) has gained prominence in microbiology, especially in treating non-invasive infections. Diseases such as mycobacteriosis, which causes localized infections and has a slow treatment, tend to be future targets for this type of technology. Therefore, this study aimed to explore the action of two isomeric Pd(II)-porphyrins on fast-growing mycobacterial strains (RGM). Tetra-cationic porphyrins (4-PdTPyP and 3-PdTPyP) were synthesized and applied against standard strains of Mycobacteroides abscessus subsp. abscessus (ATCC 19977), Mycolicibacterium fortuitum (ATCC 6841), Mycolicibacterium smegmatis (ATCC 700084), and Mycobacteroides abscessus subsp. massiliense (ATCC 48898). Reactive oxygen species (ROS) scavengers were used in an attempt to determine possible ROS produced by the photosensitizers (PS) under study. Moreover, the impact of porphyrin on the mycobacterial surface was further evaluated by atomic force microscopy (AFM), and we observed significant damage on cells walls and altered nanomechanical and electrostatic adhesion properties. The results presented herein show that the positively charged porphyrin at the meta position (3-PdTPyP) was the most efficient PS against the RGM strains, and its bactericidal activity was proven in two irradiation sessions, with singlet oxygen species being the main ROS involved in this process. This study demonstrated the therapeutic potential of porphyrins, especially the 3-PdTPyP derivative.

Keywords: Antimicrobial photodynamic therapy; Pd(II) porphyrins; Porphyrins; RGM.

MeSH terms

  • Mycobacterium*
  • Palladium
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Porphyrins* / pharmacology

Substances

  • Photosensitizing Agents
  • Porphyrins
  • Palladium